Christopher R. Fenimore - EVP Finance CFO at REGENERON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Finance CFO
Issuer Symbol
REGN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher R. Fenimore since 03 Jan 2025

Holdings reported by Christopher R. Fenimore for REGENERON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18,300 $13,046,802 $712.94 08 Dec 2025 Direct
Common Stock 1,897 $1,488,405 $784.61 05 Dec 2025 By Trust
Common Stock 1,548 $1,214,576 $784.61 05 Dec 2025 By 401(k) Plan
Common Stock 25 $19,615 $784.61 05 Dec 2025 by Trust for Daugh
Common Stock 25 $19,615 $784.61 05 Dec 2025 by Trust for Son
Non-Qualified Stock Option (right to buy) 14,924 05 Dec 2025 Direct Common Stock

Transactions reported by Christopher R. Fenimore for REGENERON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.